For research use only. Not for therapeutic Use.
TT-OAD2(CAT: I016391) is a potent non-peptide glucagon-like peptide-1 (GLP-1) receptor agonist with an EC₅₀ value of 5 nM, demonstrating high efficacy in activating GLP-1–mediated signaling pathways. Unlike peptide-based agonists, TT-OAD2 offers improved metabolic stability and oral bioavailability, making it an attractive candidate for therapeutic development. By stimulating the GLP-1 receptor, TT-OAD2 enhances insulin secretion, improves glucose tolerance, and supports glycemic control. Its strong pharmacological profile positions it as a promising tool for metabolic disease research, particularly in type 2 diabetes, where novel GLP-1 receptor modulators are being investigated as next-generation antidiabetic therapies.
| CAS Number | 2382719-60-8 |
| Synonyms | (2S)-2-[[(3S,8S)-3-[4-[(3,4-dichlorophenyl)methoxy]phenyl]-7-[(1S)-1-phenylpropyl]-3,6,8,9-tetrahydro-2H-[1,4]dioxino[2,3-g]isoquinoline-8-carbonyl]amino]-3-[4-(2,3-dimethylpyridin-4-yl)phenyl]propanoic acid;dihydrochloride |
| Molecular Formula | C50H49Cl4N3O6 |
| Purity | ≥95% |
| IUPAC Name | (2S)-2-[[(3S,8S)-3-[4-[(3,4-dichlorophenyl)methoxy]phenyl]-7-[(1S)-1-phenylpropyl]-3,6,8,9-tetrahydro-2H-[1,4]dioxino[2,3-g]isoquinoline-8-carbonyl]amino]-3-[4-(2,3-dimethylpyridin-4-yl)phenyl]propanoic acid;dihydrochloride |
| InChI | InChI=1S/C50H47Cl2N3O6.2ClH/c1-4-44(35-8-6-5-7-9-35)55-27-38-26-47-46(60-29-48(61-47)36-15-17-39(18-16-36)59-28-33-12-19-41(51)42(52)22-33)25-37(38)24-45(55)49(56)54-43(50(57)58)23-32-10-13-34(14-11-32)40-20-21-53-31(3)30(40)2;;/h5-22,25-26,43-45,48H,4,23-24,27-29H2,1-3H3,(H,54,56)(H,57,58);2*1H/t43-,44-,45-,48+;;/m0../s1 |
| InChIKey | JCHUZLPPFLKGNX-PLFFULENSA-N |
| SMILES | CCC(C1=CC=CC=C1)N2CC3=CC4=C(C=C3CC2C(=O)NC(CC5=CC=C(C=C5)C6=C(C(=NC=C6)C)C)C(=O)O)OCC(O4)C7=CC=C(C=C7)OCC8=CC(=C(C=C8)Cl)Cl.Cl.Cl |
| Chemistry Calculators | Dilution Calculator In vivo Formulation Calculator Molarity Calculator Molecular Weight Calculator Reconstitution Calculator |
